Immunotherapy Research Papers Samples For Students

Biology

Introduction
Lung cancer is a leading cause of death worldwide. Natural killer cells play a critical role in immunotherapy for cancer patients. The natural killer or NK cells play a crucial role in cancer patients and developing an understanding of the mechanisms through which their activity is inhibited or enhanced in the case of cancer patients, shall contribute a great deal in finding the most suitable and effective treatment of cancer patients and also enhance their life. The present research paper is restricted to the study of cell mechanisms involving NK cells and their inhibitor and activators in the case of patients ...

Crohn's Disease (CD): A Historical Background

Crohn’s disease is a persistent inflammatory bowel disease (IBD) that may impact any part of the gastrointestinal path, however, normally impacts the ileum (Yamada, 2009). It usually occurs to individuals of age 21 or under (Wilson et al., 2010). The CD may affect the quality of life (Baumgart & Sandborn, 2007; Morrison et al., 2009). It may need surgery (Pihl-Lesnovska et al., 2010).
There is a steady global rise in the occurrence of Crohn’s Disease and it represents an increased hospitalization (Gibson, 2009; Morrison et al., 2009; Wilson et al., 2010). In 2009, the CD cases in Australia were ...

Largely, due to its regulatory framework, cottage-industry structure and dysfunctional compensation, the healthcare sector has dejectedly underinvested in ICT. Without these essential tools and technologies, many healthcare providers do not have the capacity to transform the expanding stream of therapeutic and diagnostic advances in medical science into affordable and high quality healthcare especially in the care of the chronically ill. Technologies that enable predictable effective therapy and precise diagnosis are those that have the capacity and full potential to transform healthcare through disruption.
Christensen argues that there are two key technological enablers of disruptive innovation in healthcare. One ...

Targeted therapies that include small molecule inhibitors and monoclonal antibodies have considerably altered the cancer treatment over the past several years. These drugs are currently a part of therapy for several widespread malignancies, including colorectal, breast, pancreatic, and lung cancers, as well as leukemia, multiple myeloma, and lymphoma. The action mechanisms, as well as toxicities of targeted therapies, are different from the action mechanisms of traditional cytotoxic chemotherapy. Targeted therapies are usually better endured than traditional chemotherapy, although they are linked to a number of unfavorable effects, like cardiac dysfunction, acneiform rash, proteinuria, thrombosis, and hypertension. Small molecule inhibitors are acted ...